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Miroslav Blumenberg2, Denis Khnykin3, Frode L. Jahnsen3, Seth D. Crosby4, Narendrakumar Ramanan5 and
Tatiana Efimova1
Serum response factor (SRF) is a transcription factor that regulates the expression of growth-related immediate-
early, cytoskeletal, and muscle-specific genes to control growth, differentiation, and cytoskeletal integrity in
different cell types. To investigate the role for SRF in epidermal development and homeostasis, we conditionally
knocked out SRF in epidermal keratinocytes. We report that SRF deletion disrupted epidermal barrier function
leading to early postnatal lethality. Mice lacking SRF in epidermis displayed morphogenetic defects, including an
eye-open-at-birth phenotype and lack of whiskers. SRF-null skin exhibited abnormal morphology, hyperplasia,
aberrant expression of differentiation markers and transcriptional regulators, anomalous actin organization,
enhanced inflammation, and retarded hair follicle (HF) development. Transcriptional profiling experiments
uncovered profound molecular changes in SRF-null E17.5 epidermis and revealed that many previously identified
SRF target CArG box-containing genes were markedly upregulated in SRF-null epidermis, indicating that SRF may
function to repress transcription of a subset of its target genes in epidermis. Remarkably, when transplanted onto
nude mice, engrafted SRF-null skin lacked hair but displayed normal epidermal architecture with proper
expression of differentiation markers, suggesting that although keratinocyte SRF is essential for HF development,
a cross-talk between SRF-null keratinocytes and the surrounding microenvironment is likely responsible for the
barrier-deficient mutant epidermal phenotype.
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INTRODUCTION
The epidermis, a multilayered self-renewing tissue, functions
as a barrier against environmental assaults and dehydration.
The barrier is first established during embryonic development
through the activation of a tightly regulated epidermal differ-
entiation program (Koster, 2009). Disturbances in barrier
function are linked to various pathologies, from congenital
ichthyoses to inflammatory skin diseases including psoriasis
and atopic dermatitis (reviewed in Segre, 2006). Upon sensing
barrier breach, epidermal cells turn on the expression of stress-
responsive genes initiating proinflammatory cytokine produc-
tion and stimulation of local and systemic immune responses,
which creates a microenvironment supporting epidermal
hyperproliferation and wound response. Conversely, prolonged
or aberrantly initiated lymphocyte activation and/or kerati-
nocyte proliferation disturb epidermal homeostasis, and cause
or aggravate barrier defects. Thus, determining the contribu-
tions from epithelial and immunologic components is critical
for understanding the molecular mechanisms underlying
development and diseases of the skin.
Serum response factor (SRF) transcription factor regulates
the growth and differentiation gene expression programs
(Soulez et al., 1996; Koegel et al., 2009; Sandbo et al.,
2009; Stritt et al., 2009; Ragu et al., 2010a, b). SRF is activa-
ted through the mitogen-activated protein kinase or RhoA
pathways, and elicits rapid transcriptional response through
the regulation of transcription factors, signaling proteins, and
cytoskeletal components (Posern and Treisman, 2006; Miano
et al., 2007). SRF target genes contain single or multiple
copies of the consensus CArG box to which SRF binds through
MADS domain (Miano, 2003). Recently, several lines of
epidermal-specific SRF knockout mice have been independently
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reported to display a spectrum of epidermal phenotypes
including keratinocyte hyperproliferation (Koegel et al.,
2009; Verdoni et al., 2010; Luxenburg et al., 2011), lympho-
cyte infiltration, abnormal barrier formation (Verdoni et al.,
2010), aberrant spindle orientation and cell shape (Luxenburg
et al., 2011), and development of psoriatic phenotype (Koegel
et al., 2009). In vitro, SRF transcriptional activity has been
implicated in promoting keratinocyte differentiation on micro-
patterned substrates (Connelly et al., 2010).
Here we further explore the role of SRF in regulating
epidermal development and function using a skin-grafting
approach in addition to a conditional knockout model. We
report several important findings. First, the differentiation/
proliferation defects observed in SRF mutant skin are inti-
mately coupled with the activation of immune/inflammatory
response, as SRF-null epidermis develops normally when
grafted onto nude mice. Second, SRF is required for proper
development of hair follicles (HFs), and this requirement is
intrinsic to epidermis and does not depend on lymphocytes.
Finally, we demonstrate several genes/pathways potentially
involved in mediating the SRF-regulated downstream events,
and reveal a repressor role for SRF in regulating the expression
of a subset of its target genes in epidermis.
RESULTS
Characterization of mice lacking Srf in epidermis
SRF is expressed in neonatal mouse interfollicular epidermis
and HFs (Supplementary Figure S1a online). Conditional
mutants with epidermal-specific Srf ablation K14-Creþ / ;
Srffl/fl (Srf-cKO) (Supplementary Figure S1b online), generated
by crossing mice homozygous for a floxed Srf allele (Srffl/fl)
(Ramanan et al., 2005) with Keratin14-Cre-expressing mice
(K14-Cre) (Dassule et al., 2000), were born at expected
Mendelian ratio. The efficient epidermal Srf deletion was
confirmed by immunoblot (Figure 1e). Srf-cKO mutants lacked
visible skin lesions including scaling, peeling, or erosions,
but exhibited wrinkled skin, eye-open-at-birth phenotype
(Figure 1a; Supplementary Figure S1c and d online), mal-
formation of hind limbs, including splaying and hemorrhaging
of the digits (Figure 1b, lower panel; Supplementary Figure
S1e online), and lack of whiskers (Figure 1b, upper panel).
Mutants died or were eliminated by their mothers within
6hours of natural birth. Upon E18.5 caesarean delivery, unfed
Srf-cKOs survived for at least 31hours at room temperature,
and died of apparent dehydration (Figure 1d).
Defective epidermal barrier formation in Srf-cKO mutants
The ‘‘outside-to-inside’’ barrier was assessed using acidic
X-gal dye penetration assay (Hardman et al., 1998). Srf-cKO
mutants showed normal ability to exclude penetration of X-gal
through their skin, except around digits of hind limbs
(Figure 1c), indicating that the ‘‘outside-to-inside’’ barrier
was not generally affected by epidermal Srf loss. Hourly
assessment of body weight of unfed E18.5 mice revealed a
steady weight loss in mutants, but not in wild-type littermate
controls, throughout the measurements period (within about
30hours after birth) (Figure 1d), indicating a possibility of
increased transepidermal water loss because of impaired
‘‘inside-to-outside’’ epidermal barrier function in mutants.
Indeed, Srf-cKO skin acquired a markedly desiccated appear-
ance during this period (not shown). These data suggest that
mutant mice die perinatally from dehydration because of a
failure to acquire a functional epidermal permeability barrier.
Similar perinatal lethalities have been reported for other
barrier-deficient mouse models (Segre et al., 1999; Furuse
et al., 2002; Tunggal et al., 2005; de Guzman Strong et al.,
2006).
Srf-cKO mutant skin displays striking phenotypic abnormalities
Epidermal Srf loss resulted in an abnormal epidermal archi-
tecture with marked hyperplasia and a lack of a discernible
granular layer (Figure 1f). Srf-cKOs displayed microblistering
phenotype (Supplementary Figure S1f online). E17.5 mutant
epidermis exhibited abnormal hyperproliferation in the basal
layer as evidenced by an increased number of BrdU-positive
basal keratinocytes (a mean of 58±5% of BrdU-positive
cells in mutant, versus 19±4% in control, per field at 40
magnification; n¼ 3 embryos, four to six fields per embryo for
each genotype; P¼ 1.3710 9; Figure 1g), increased num-
ber of keratin 14-expressing layers (Figure 1g), and upregula-
tion of keratins 6 and 17, the indicators of perturbed epidermal
homeostasis (Figure 1l; Supplementary Figure S2c online).
In addition, extensive apoptosis was detected in suprabasal
layers of SRF-null epidermis (Figure 1h). Loss of Srf led to
perturbed expression patterns of terminal epidermal differen-
tiation markers, including loricrin, keratin 10, and involucrin
(Figures 1i and 2a,b).
SRF-null E17.5 skin showed increased density of infiltrating
CD45þ cells in the dermis, indicating increased inflammation
compared with wild-type littermate control skin (Figure 1j).
Furthermore, Srf loss in keratinocytes caused cortical actin
cytoskeleton disruption, abnormal increase in suprabasal
expression of hemidesmosomal integrin b4 (Figure 1k), and
decrease in suprabasal b-catenin expression at cell–cell
contacts (Figure 1m).
The expression patterns of transcription factors implicated in
control of epidermal gene expression are perturbed in mutant
epidermis
Srf-cKOs displayed perturbed expression patterns of transcrip-
tion factors implicated in the regulation of epidermal tran-
scription and terminal differentiation, including DNp63a, AP1,
and C/EBP. We observed a partial loss of DNp63a from the
nuclei of basal keratinocytes in mutant epidermis (Figure 2c).
Srf ablation led to altered expression and localization of Fra-1,
JunB, and c-Jun AP1 family members, and C/EBPa transcrip-
tion factor (Figure 3). As reported (Welter and Eckert, 1995), in
wild-type epidermis, Fra-1 expression was cytoplasmic and
involved all epidermal layers, except basal. In contrast, in Srf-
cKO, Fra-1 was localized mainly to basal nuclei (Figure 3a). In
wild-type epidermis, JunB was expressed in the suprabasal
nuclei, whereas in mutant staining was more intense in
the basal nuclei (Figure 3b). c-Jun expression was observed
in the nuclei of basal and suprabasal keratinocytes in wild-
type, but exhibited intermittent appearance in mutant epider-
mis (Figure 3c). C/EBPa was highly expressed in suprabasal,
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Figure 1. Phenotypic and biochemical changes in Srf-cKO epidermis (epi). (a) Postnatal day 0 (P0) wild-type (wt) and mutant (mt) mice. (b) EOB phenotype, lack
of whiskers, and abnormal hind limb digits in mutants. E18.5, embryonic day 18.5. (c) Acidic X-gal dye penetration assay. (d) Dehydration assay. Steady
weight loss exhibited by mutants but not by wt control littermates, suggesting defective ‘‘inside-to-outside’’ barrier in mutants. (e) Immunoblot confirms serum
response factor (SRF) ablation in mutant epidermis. Tubulin immunoblot verifies equal protein loading. (f) H&E and (g–m) immunofluorescent staining of E17.5 wt
and mt littermate skin sections, using the indicated antibodies, color coded according to secondary antibodies. Secondary antibody alone was used as a
negative control for each primary antibody (not shown). Nuclei were counterstained with Hoechst dye. bcat, b-catenin; der, dermis; Intb4, integrin b4; Ker, keratin;
Lor, loricrin. Bar¼50mm.
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and weakly in some basal keratinocytes in wild-type
epidermis, as reported by Oh and Smart (1998), and the
expression was markedly reduced in SRF-null epidermis
(Figure 3d).
HF morphogenesis in Srf-cKO is abnormal
Our analyses showed that the downgrowth of HFs in mutants
was apparently less extensive than that of littermate controls
(Figure 1f–m). We next performed alkaline phosphatase
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Figure 2. Abnormal expression of keratin 10, involucrin, and p63 in the epidermis of Srf-cKO mice. Immunohistochemical analysis of wild-type (wt) control and
SRF-null mutant (mt) postnatal day 1 (P1) mouse skin sections for (a) keratin 10 and (b) involucrin expression. Positive staining is shown by brown staining.
Secondary antibody alone was used as a control (No 1o Ab). Original magnification, 40. (c) Immunofluorescent staining using antibodies specific for the
indicated proteins in wt control and SRF-null mt P1 mouse skin sections. Secondary antibody alone was used as a negative control for each primary antibody
(not shown). Nuclei were counterstained with Hoechst dye (DNA). Bar¼ 50mm.
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staining on E18.5 control and Srf-cKO skin sections to
determine the position of dermal papilla cells, which mark
the end of HF. Indeed, the alkaline phosphatase–stained
dermal papilla cells in mutants are much closer to epidermis
than their wild-type counterparts (Supplementary Figure S3a
online), especially considering that Srf-cKO epidermis is
thicker than wild type. In addition, the overall number of
HFs in E18.5 mutant skin is 25% lower relative to that in
controls (Supplementary Figure S3b online) and HFs in mutant
skin are at the earlier developmental stages compared with
those in their wild-type counterparts (Supplementary Figure
S3c online).
Engrafted SRF-null skin lacks hair but exhibits normal epidermal
architecture and proper expression of differentiation markers
Srf-cKO embryonic and neonatal skin exhibited typical fea-
tures of human inflammatory skin pathology including barrier
breach, hyperkeratosis, and enhanced lymphocytic infiltration.
However, these phenotypes are often interconnected and each
feature might be a part of the positive-feedback loop. Thus, we
sought to graft full-thickness skins from E17.5 mutants and
wild-type control littermates onto the backs of nude mice, to
distinguish the contribution from epithelial compartment and
infiltrated lymphocytes, and to circumvent early neonatal
lethality of mutants. We observed robust hair growth in
wild-type grafts throughout the course of the experiment
(14 weeks). In contrast, SRF-null mutant grafts showed very
limited and abnormal hair growth at all stages examined
during the same period (Figure 4a).
As nude mice also exhibit defective HF development, we
evaluated whether grafted epidermis is solely derived from
SRF-null cells. In nude mice, a well-characterized mutation
in FoxN1 gene results in a disruption of FoxN1 nuclear
localization signal preventing a truncated protein from enter-
ing the nucleus (Schorpp et al., 2000). Conversely, Srf-null
mutants carry wild-type FoxN1 alleles, which produce protein
localized to nucleus. We detected nuclear FoxN1 expression
in all epidermal cells from grafted mutant skin, but not in host
nude mouse skin (Supplementary Figure S4 online), indicating
that grafted epidermis is solely derived from SRF-null cells.
Srf-cKO grafts displayed largely normal epidermal architec-
ture similar to that of grafted skin from control mice, apart
from the lack of HFs (Figure 4b). Intriguingly, the expression
patterns of differentiation markers involucrin and loricrin, both
dysregulated in Srf-cKO skin at late embryonic stages, were
indistinguishable between grafted skin of different genotypes
(Figure 4b). Moreover, keratin 6, a perturbed epidermal
homeostasis indicator, highly induced in E17.5 mutant epi-
dermis (Figure 1l), was undetectable in Srf-cKO graft (not
shown). Similarly, expression of TSLP, a sensitive measure
of the barrier integrity (Demehri et al., 2008), was upregulated
in embryonic but absent from grafted mutant skin (Figure 4c).
In addition, increased epidermal thickness and apoptosis, the
prominent features of Srf-cKO embryonic epidermis, were not
observed in grafted mutant skin (Figure 4d). Collectively, no
difference in epidermal histology or marker expression was
detected between mutant and control grafted skin. These data
are in contrast with previous findings showing severe psoriasi-
form changes in SRF-deficient young postnatal mice (Koegel
et al., 2009), and suggest that inflammatory activity has a key
role in mediating the progression of the phenotype in SRF-null
skin. Conversely, the lack of hair in grafted skin indicates
that HF deficiency is a manifestation of intrinsic epidermal
anomalies in the absence of SRF, and not the result of
inflammatory or immunological processes.
Global gene expression changes in SRF-null epidermis
To explore the molecular mechanisms underlying the effects
of SRF loss on epidermal homeostasis and barrier acquisition,
we conducted microarray studies using E17.5 SRF-null and
wild-type control epidermal RNA samples. Our analysis
identified 1124 and 342 probe sets upregulated and down-
regulated, respectively, by more than 2-fold in mutant samples
(Po0.1; Supplementary Table S1 online). Figure 5a and b
shows selected genes differentially expressed in mutant epider-
mis, grouped into functional categories. Changes in expression
of selected genes were validated by reverse transcriptase–PCR,
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Figure 3. Aberrant patterns of expression of the AP1 family members
Fra-1, JunB and c-Jun, and C/EBPa transcription factors in epidermis (epi)
lacking serum response factor. Immunofluorescence (upper panel) and
immunohistochemical analyses of wild-type (wt) and Srf-cKO mutant (mt)
E18.5 mouse skin sections for the expression of the indicated transcription
factors. Nuclei were counterstained with Hoechst dye (upper panel). Positive
staining for JunB, c-Jun, and C/EBPa is shown by brown staining. Secondary
antibody alone was used as a negative control for each primary antibody (not
shown). der, dermis. Bar¼50mm.
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in situ hybridization, western blot, or immunofluorescence
(Supplementary Figure S2 online; Figure 1i, k, and l, data not
shown).
Notably, microarray data revealed that many purported SRF
target genes are markedly upregulated in SRF-null epidermis
(Figure 5c), suggesting a potential repressor function for SRF
for a subset of its epidermal targets (Ernst et al., 1995; Sun
et al., 2006). As expected, the CArG-containing genes, that is,
target genes for the MADS transcription factor family, are the
most prominent ones in the downregulated category
(Supplementary Table S2 online). In contrast, the reticuloen-
dotheliosis viral oncogene homologs (REL) family targets are
the most prominent among the upregulated genes
(Supplementary Table S2 online), reflecting the inflammatory
and immune responses elicited in SRF-null epidermis and the
role of NFkB in this process (Banno et al., 2004, 2005).
Analysis of the ontological categories of regulated genes
pinpointed a Chromosome 3 cytoband 45.2 cM locus as
highly enriched (Figure 5a, Supplementary Table S3 online);
this region contains 11 small proline-rich proteins, the
cornified envelope components. This upregulation may be
responsible for the efficient ‘‘outside-to-inside’’ barrier of SRF-
null epidermis. The ‘‘keratinization’’ category also contains
keratin genes 6 and 17, markers of hyperproliferative epider-
mis (Schermer et al., 1989), but not any of the paradigmatic
differentiation markers, such as keratins 1/10, filaggrin,
loricrin, or involucrin. The genes associated with wounding
and inflammatory responses are prominently upregulated in
SRF-null epidermis (Figure 5a; Supplementary Tables S3 and
S4 online). tumor necrosis factor-a, one of the primary
upregulators of inflammation and inflammation-associated
genes in human epidermis (Banno et al., 2004, 2005), is
21d 35d 97d
mt graft
wt mt
TSLP DNA
mt (no 1° Ab)
wt graft
G
ra
ft,
 9
7d
wt graft, 97d
mt graft, 97d
mt, E17.5
Ker14 TUNEL DNA
E1
7.
5
wt graft, 97d
Inv
Lor
No1° Ab
mt graft, 97d
Figure 4. Engrafted serum response factor–null skin lacks hair but exhibits normal epidermal architecture and proper expression of differentiation markers.
Wild-type (wt) and mutant (mt) E17.5 skins were engrafted onto the backs of nude mice. (a) General appearance of the grafts at the indicated days post grafting.
(b) Histological and immunohistochemical analyses, using the indicated antibodies, of the 97-day (97-d) grafts. Positive staining is shown by brown staining.
(c) Immunofluorescence analysis of TSLP expression. Secondary antibody alone was used as a negative control in both b and c (No 1o Ab). (d) TUNEL assay reveals
no TUNEL-positive cells in the 97-d wt or mt grafts. In contrast, E17.5 mt sample used as a positive control shows numerous TUNEL-positive nuclei in epidermis.
Nuclei were counterstained with Hoechst dye. d, days; Inv, involucrin; Ker, keratin; Lor, loricrin. (b–d) Bar¼ 50mm.
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among the induced genes in this category (Supplementary
Table S4 online). The most significant categories among the
downregulated genes include amino acid metabolism, lipo-
proteins, and lipid metabolism (Supplementary Table S3
online). This downregulation of lipid metabolism and lipopro-
teins may be responsible for the defective ‘‘inside-to-outside’’
barrier and water loss of SRF-null mutants.
Importantly, we detected the downregulation of the genes
linked to HF development and differentiation, including Wnt/
b-catenin pathway members, Shh pathway member Ptch1,
hair-associated keratins Krt32 and Krt34, and stem cell-
associated Krt15, in E17.5 mutant epidermis (Figure 6a). These
findings were confirmed by in situ hybridization (Lef1, Ptch1,
and Shh, Figure 6b, d, and e) and immunohistochemistry
(Lef1, Figure 6c). Notably, Lef1 expression in mutant E15.5
epidermis was similar to that in littermate control epidermis
(Supplementary Figure S5 online). Conversely, the expression
of negative regulators of Wnt/b-catenin signaling, such as
Wif1, Sfrp1, and Gsk3b, was upregulated in mutant E17.5
epidermis (Figure 6a). Notably, the promoters of Lef1, Fzd2,
and Ptch1 genes contain conserved CArG boxes, and the
promoters of Krt34, Krt32, Gata3, and Edar genes contain
conserved CArG box–like sequences (a consensus sequence
with one base-pair deviation) (Sun et al., 2006; Benson et al.,
2011), indicating a potential for SRF to directly bind and
transactivate the transcription of these genes. Importantly, we
Categories
Cytoband 3 45.2
cM/keratinization
Krt2-6b (327), Krt2-6a (217), Sprr2g (112.8), Sprr2f (79.9),
Sprr4 (39) Sprr1a (32.4), Krt1-16 (32), Sprr2e (28.6), Sprr2k
(27.8), Rptn (16), Sprr2b (12), Sprr2h (8.3), sprr2i (5.8),
Sprr2j (5.2), Sprr1b (4.5), Sprr2d (4.5), Sprr2a (2.5), Krt1-17
(2.1)
IL8 family Cxcl1 (129), Ccl20 (51), Cxcl10 (6.8), Ccl7 (6.2), Ccl4 (6),
Ccl2 (4.7), Cxcl9 (4.3), Ccl21b (4.2), Ccl21c (3.7), Cxcl2
(3.3), Cxcl4 (2.8), Ccl12 (2.6)
S100a8 (339), S100A9 (130), Cxcl1 (129), Ccl20 (51), Saa1
(19.4), Elk3 (7.4), Thbd (7.4), Tnf (7), Cxcl10 (6.8), Dtr (6.4),
Ccl7 (6.2), Ccl4 (6), Elf3 (5.3), Ccl2 (4.7), F2rl1 (4.3), Cxcl9
(4.3), Ccl21b (4.2), Nfkbiz (4.2), Dyst (4.2), Hdac7a (3.8),
Ccl21c (3.7), Cxcl2 (3.3) Pla2g7 (3.3), Fcgr2b (3),
Serpina3n (3), Cxcl4 (2.8), Serping1 (2.7), Ccl12 (2.6), Alox5
(2.5), Efemp2 (2.5), sox15 (2.5), Saa4 (2.4), Tgfb1 (2.3),
Stat3 (2.3), Zfp36 (2.3), Cfd (2.2), Cd44 (2.2), Stab1 (2.1)
S100a8 (339), Ccl20 (51), Cxcl10 (6.8), ll8rb (6.6), Cxcl16
(6.5), Ccl7 (6.2), Ccl4 (6), Ccl2 (4.7), Ccl21b (4.2), Ccl21c
(3.7), ll8ra (3.7), Cxcl2 (3.3), Cxcl4 (2.8), Enpp2 (2.8), Ccl12
(2.6), C5r1 (2.3), Slit2 (2)
Shrm (15), Cldn3 (9.2), Vcam1 (8.7), Pcdh21 (5), Pvrl1 (4.4),
Emcn (4), Gp38 (3.4), Pcdh10 (3.4), Cldn4 (3.3), Gm1010
(3.2), ltgb1 (3.1), Egfr (3), Cdh11 (3), Esam1 (2.9), ltga3
(2.9), lcam1 (2.8), Cldn5 (2.7), ltgb4 (2.6), Adam8 (2.6),
Efemp2 (2.5), Pcdh1 (2.5), ltgb8 (2.3), Pcdh7 (2.3), Cldn10
(2.3), Scarf2 (2.2), Cldn11 (2.2), ltgav (2.2), Tjp2 (2.2),
Amigo1 (2.1), Pvrl2 (2.1), Psc1 (2.1), ltga6 (2), Tjp1 (2)
Epgn (32), Areg (20), Bcl3 (12.3), Fgf1 (11.3), lgfbp6 (8), Dtr
(6.4), Fgf10 (3.6), Egfr (3), Fgf7 (2.9), Rhob (2.7), Fgf1 (2.5),
lgf2r (2.2), lgf2bp1 (2), lgf2bp2 (2)
Mmp3 (138.5), Thbs2 (11.5), Col1a1 (5.4), Col6a1 (5.2),
Lama1 (5), Tnc (4.4), Mmp13 (3.8), Col18a1 (3.2), Mmp1a
(2.9), Col6a3 (2.8), Tns4 (2.6), Eln (2.6)
Response to
wounding
Chemotaxis
Cell–cell
adhesion
Growth/survival
signaling
Extracellular
matrix associated
Categories
Edpidermal
differentiation/
keratinization
Lipid
biogenesis/
lipid processing
Cell–cell
adhesion
Growth/survival
signaling
Extracellular
matrix
Cytoskeleton
Transcriptional
regulation
Inflammation
mRNAs: >1.5-fold down by microarray
mRNAs: >2-fold up by microarray wt mt
Barx2*
Tuft1*
Lzf
Efha1
Txnip
I117rb
Thbs1*
Itab1bp
Hoxc6
Actb*
Mrrf
Bc12*
Pdlim2
Dm15
Slc40a1
Hoxb7
Rec8L1
Slc15a2
Cdk5rap3
Fh11
AU040320
Lef1
Shkbp1
Itm2b
Numb
Phvhip
Junb*
Cuabp2
Fh12*
Kcnk1
Pmp22 *
Tcf2
Pdafra
Tpm1
Slc2a1*
Ldb2
Ear2
P1p2
Capza3
Rhoe
Mrgorf
Tpm2 *
Krt1-17*
Elf5
Agpt2
Igf2
Cdh11
Crvab*
Copeb
Tgm1
2610001E17RiK
Cvr61
Mvlk *
Slc9a1
Fgf10
Traf4
Dusp6
Dusp2*
Ipo4
lI13ra1
Galnt3
Elf3
3200002M19Rik
Krt1-16 (–16), Krt1-2 (–6.4), Krt2-39/Krt77 (–5.9), Krt78 (–5.2),
Krt1-15 (–4.7), Krt1-4 (–3.8), Casp14 (–2.8), Tgm3 (–2.5),
Ppl (–2.2), Lor (–1.7), Eppk1 (–1.6)
Adh1 (–18.4), Alox12 (–10.5), Crgl1 (–4.9), Plscr1 (–4.6),
Asah3 (–3.7), Gpld1 (–3), Chdh (–3), Fabp6 (–2.9),
Mlycld (–2.8), Plb1 (–2.7), Hyal4 (–2.6), Lipn (–2.5), Sts (–2.3),
Hsd3b2 (–2.3), Pla2g12a (–2), Pla2g5 (–2), Pla2g4b (–2)
Pcdh20 (–29), Tjp3 (–9.6), Thbs3 (–6.7), Catns/p120 (–3.7),
ltgae (–2.3)
Btc (–4.6), Figf (–3.4), Fgf13 (–3), Fgfr3 (–3), Pdgfb (–2.9),
Araf (–2.2), Fgfbp3 (–2.6), Bcl2 (–1.5)
Col4a6 (–2.4), Col4a5 (–2.3), Mmp2 (–1.9), Col16a1 (–1.8)
Gsn (–3.5), Palm (–3.6), Actb (–3.3), Add3 (–3.2), Tmod4 (–2.6),
Snta1 (–2.5), Mylk (–2.5), Myom2 (–2.3), Myo1f (–2.3),
Tnni (–2.2), Pfn2 (–2.2), Nich1 (–2.1)
Lmyc1 (–4.7), Hoxd8 (–4), Barx2 (–3), Pou3f1 (–2.9),
Mxd4 (–2.7), Ovol2 (–2.4), Stat5a (–2.4), Hoxd4 (–2)
II20rb (–7), II15 (–6.5), Spink3 (–5.5), II17rb (–3.5),
Cxcl14 (–2.5), II13 (–1.8), II1f8 (–1.6)
a
b
c
Figure 5. Changes in the expression of selected genes in serum response factor (SRF)–null epidermis. Selected genes (a) upregulated or (b) downregulated in
mutant E17.5 epidermis, grouped into functional categories essential for skin barrier function. Numbers in parenthesis correspond to fold (a) increase or (b)
decrease in Srf-cKO mutant versus wild-type (wt) control epidermis. P-value is less than 0.1. (c) Heat map shows both downregulation and upregulation of SRF
target CArG-containing genes. A summary of SRF target genes, containing known and novel CArG sequences, generated using bioinformatics screen was published
by Sun et al., 2006. About 60% of the putative SRF target genes have been functionally validated in that study. *Known CArG-containing SRF target genes, as
reported in the aforementioned study.
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observed a decrease in the Lef1 promoter-luciferase reporter
activity in cultured mouse keratinocytes upon endogenous
SRF depletion (Supplementary Figure S6a and c online),
indicating a downregulation of Wnt activity. In contrast,
activation of the SRE-luciferase reporter (a construct that
contains a multimerized CArG box and adjacent E twenty-
six binding site) was increased following SRF depletion
(Supplementary Figure S6b online), supporting the notion that
SRF can function as a cell autonomous transcriptional repressor
of certain target genes in epidermal keratinocytes (Figure 5c).
DISCUSSION
Here we analyzed the role of SRF in epidermal development
and function by characterizing epidermal-specific Srf-cKO
mutant. In part, our findings are consistent with other studies
(Koegel et al., 2009; Verdoni et al., 2010; Luxenburg et al.,
2011), which demonstrated a marked morphological change
in SRF-deficient epidermis. Nonetheless, by showing that SRF-
null skin develops normally when grafted onto immune-
compromised nude mice, we provide evidence that most of
these epidermal changes are dependent on inflammatory
activity. In addition, we demonstrate an obligatory role for
SRF in the development of HFs. Moreover, global gene
expression profiling revealed an unexpected repressor role
for SRF in regulating a subset of its downstream epidermal
targets. The notion that SRF can function as a cell-autonomous
transcriptional repressor is supported by our finding that the
activity of SRE promoter is upregulated following SRF deple-
tion in cultured keratinocytes. Alternatively, an antagonistic
regulation of distinct subsets of SRF target genes could stem
from a recently described negative-feedback circuit between
the actin-MAL and the mitogen-activated protein kinase–
ternary complex factor pathways, both of which regulate the
SRF-dependent transcription (Descot et al., 2009).
The Srf-cKO epidermal defects are intimately coupled with
augmented immune/inflammatory response
Several reports including our present study have demonstrated
the role of SRF in maintaining epidermal homeostasis (Koegel
et al., 2009; Verdoni et al., 2010; Luxenburg et al., 2011).
Koegel et al. reported a sustained inflammation in young mice
with patchy Srf depletion, and proposed that increased kera-
tinocyte proliferation is regulated by lymphocyte activation,
whereas adhesion defects reflect keratinocyte SRF cell-
autonomous requirement in regulating actin cytoskeleton.
Luxenburg et al. reasoned that spindle defects and abnormal
mitotic division caused by cortical actin network deficiency
are the underlying mechanisms for the proliferation and differ-
entiation defects observed in mutant embryonic epidermis, as
these defects occur before the infiltration of immune cells.
We studied Srf-cKO skin in both embryonic/neonatal stages
and in a skin graft model, and demonstrated that most
embryonic anomalies, other than the HF defect, do not
persist or progress when grafted onto nude mice. In grafted
mutant skin, both proliferation and differentiation are com-
parable to wild-type controls 14 weeks post grafting. This
contrast between grafted skin and skin from neonatal or young
mutant mice (Koegel et al., 2009) suggests a role for inflam-
mation in the progression of the psoriasis-like phenotype.
Indeed, the largest functional group of genes upregulated in
SRF mutant epidermis are those involved in wound response,
including many proinflammatory cytokines and chemokines
produced by either keratinocytes or infiltrated lymphocytes.
It is plausible that SRF mutant skin initially develops mild
abnormalities including cell shape changes reported by
Luxenburg et al. (2011). In turn, keratinocytes sense these
changes and initiate wound response, which sustains and
aggravates abnormal epidermal phenotype. The induction of
proinflammatory cytokines, notably tumor necrosis factor-a,
Wnt/β-catenin pathway
Shh pathway
Hair shaft keratins Krt32 (–4.7), Krt34 (–3.8)
Krt15 (–4.7)
Edar (–1.8), Edaradd (–2.45), Gata3 (–1.5)
Stem cell associated
Hair follicle development
Wt
Lef1
Ptch1
E17.5
Shh
Lef1
mt
Negative regulation of
Wnt/β-catenin signaling
Wif1 (2.5), Sfrp1 (3.8), Gsk3b (3.0)
Wnt16 (–3.6), Wnt7a (–2.7), Wnt7b (–2), Wnt12
(–2), Lef1 (–3.9), Fzd2 (–2.6), Axin (–1.8)
Ptch1 (–3.6)
Downregulated genes
Upregulated genes
Figure 6. Serum response factor(SRF)–null E17.5 epidermis exhibits reduced
expression of Lef1, Ptch1, and Shh. (a) Changes in the expression of selected
genes linked to hair follicle morphogenesis in SRF-null E17.5 mouse epidermis.
Numbers in parenthesis correspond to fold change in Srf-cKO mutant (mt)
versus wild-type (wt) control epidermis; negative values represent fold
decrease. Fold change41.5, P-value cutoff: 0.1. (b, d, and e) 35S in situ
hybridization on wt and mt E17.5 mouse skin sections using indicated probes.
Nuclei were counterstained with Hoechst dye (blue). (c) Immunohistochemical
analysis of wt and mt E17.5 mouse skin sections for Lef1 expression. Positive
staining is shown by brown staining. Secondary antibody alone was used as a
negative control for each primary antibody (not shown). (b–e) Bar¼ 200mm.
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and the activation of REL family transcription factors
(Supplementary Tables S3, S4 online) support this idea.
Whether the barrier disturbance is the cause or the result of
immune activation remains to be determined. Future experi-
ments crossing Srf-cKO to Rag1-deficient mutant lacking
mature B and T lymphocytes will provide insight into this
question. Epithelial–mesenchymal interaction might also con-
tribute to abnormal Srf-cKO epidermal phenotype offering
additional levels of complexity.
SRF in mediating HF development
Defective HF development in Srf-cKO mutants reflects an
autonomous requirement for SRF in epidermis as grafted
mutant skin is largely hairless. In addition, Srf-cKOs displayed
impaired HF downgrowth and a reduction in the overall
number of follicles. E15.5 mutant skin exhibited normal HF
structure and marker gene expression, indicating normal
primary HF induction. However, at a later time point, mutant
follicular cells showed decreased signaling activity and their
development was arrested. The cluster of HF defects in Srf-
cKO likely reflects a dynamic role for SRF in different cell
types at different developmental stages. The molecular
mechanisms underlying these defects remain to be further
elucidated, as the current model does not allow us to dissect
the function of SRF in different hair compartments at different
developmental stages. Nonetheless, we have shown that the
activity of the Wnt pathway is downregulated in Srf-cKOs.
Canonical Wnt signaling is critical for HF development
(Huelsken et al., 2001). Our data show that canonical Wnt
ligands, mediators, and downstream targets are downregu-
lated in Srf-cKO, and several Wnt inhibitors are upregulated,
suggesting a specific inhibition of the pathway. Moreover,
Wnt transcriptional activity is downregulated upon SRF
depletion in cultured keratinocytes. In addition, a reduced
expression of other key regulatory genes including Shh/Ptch1
and Edar/EdarADD are also noted in the mutant. It is plausible
that the alteration of these important pathways contributes to
the Srf-cKO HF phenotype. Hedgehog signaling pathway is of
particular interest, as Shh is required for HF downgrowth
(St-Jacques et al., 1998), which is clearly impaired in
Srf-cKO. The Wnt signaling has been implicated in multiple
aspects of HF biology including placode specification
(Andl et al., 2002), follicular morphogenesis and stem
cell maintenance (Huelsken et al., 2001), and follicular
downgrowth (Zhang et al., 2008) and differentiation (Merrill
et al., 2001). Lef1-null mutant mice have a reduced number
of HFs arrested at an earlier stage of development (van
Genderen et al., 1994). The reduction in Wnt activity and
downregulation of Lef1 correlates well with the partial loss
and developmental arrest of the HFs in Srf-cKO. Whether
it also affects stem cell compartment and hair cycling remains
to be probed.
The HF is a complex structure that contains multiple cell
types and undergoes cyclic regeneration. Therefore, the role
for SRF in HF development is likely to be dynamic and context
dependent. Both Shh and Lef1 are mainly expressed in the
matrix cells, a transit amplifying cell population giving rise to
the hair shaft and the inner root sheath, which prompted us to
test the function of SRF specifically in these cell populations
using a previously described Doxycycline inducible matrix
cell–specific Msx2-rtTA;tetO-Cre system (Lin et al., 2009).
However, deletion of SRF at P0 caused only mild hair abnor-
malities in the first and second hair cycle (Supplementary
Figure S7 online), indicating that a defect in matrix cells alone
is not sufficient to cause a hairless phenotype, and suggesting
potential key functions for SRF in other follicular cell types
especially the outer root sheath, including bulge stem cells.
Future analyses using cell type–specific conditional knockout
approaches need to be performed to further dissect the
function of SRF in different hair compartments.
MATERIALS AND METHODS
Skin-targeted SRF knockout mice
Animal studies were approved by WUSM Animal Studies Committee.
Srffl/fl (Ramanan et al., 2005) and Keratin14-Cre-expressing mice
(Dassule et al., 2000) have been described.
Skin barrier assays
A dye penetration barrier assay was carried out as described
(Hardman et al., 1998). Briefly, unfixed newborn mice were rinsed
in phosphate-buffered saline (PBS) and stained at 37 oC for 12hours in
X-gal solution (pH 4.5). The samples were fixed post staining in 4%
paraformaldehyde in PBS at room temperature for 1 hour, washed
in PBS, and photographed with a digital camera. Dehydration assay
was performed as previously described (Segre et al., 1999). Briefly,
we monitored body weights of unfed E18.5 wild-type control and Srf-
cKO mutant littermates hourly during the evaluation period, as shown
in Figure 1d. The results are presented as a percentage of the initial
weight.
Histology, immunofluorescence, and immunohistochemistry
Histology, immunofluorescence, and immunohistochemistry were
performed as detailed in the Supplementary Materials online.
In situ hybridization
In situ hybridization was performed as described (Wilkinson, 1992).
Lef1 (Ramanan et al., 2005), Shh (Bitgood and McMahon, 1995), Klf4
(Huang et al., 2005), and Sprr2a (Huang et al., 2005) anti-sense
probes were as reported.
Skin grafts
Female athymic nude mice recipients (Charles River) were anesthe-
tized, 1 cm2 piece of skin per graft was removed. E17.5 Srf-cKOs and
littermate control donors were killed, similar-sized pieces of back skin
removed and grafted onto recipients.
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